Cleared Traditional

K931424 - MAXIMA I

K931424 is an FDA 510(k) clearance for MAXIMA I, manufactured by Staodyne, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 74-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1993
Decision
74d
Days
Class 2
Risk

K931424 is an FDA 510(k) clearance for the MAXIMA I. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Staodyne, Inc. (Longmont, US). The FDA issued a Cleared decision on June 4, 1993 after a review of 74 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K931424

510(k) Number K931424 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 22, 1993
Decision Date June 04, 1993
Days to Decision 74 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
75d faster than avg
Panel avg: 149d · This submission: 74d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K931424.
PMI TENS ELECTRODE
K932849 · Pepin Mfg., Inc. · Jan 1994
NEUTRALIZER
K932320 · Smith and Nephew Donjoy, Inc. · Oct 1993
COM-TENS (SINGLE MODE)
K931570 · Ems Dist. · Jun 1993
MICROCARE(TM)
K926326 · American Imex · Jun 1993
INTEGRITY 2
K923970 · Medrotech Corp. · May 1993
K-STIM CLEAR
K922202 · Katecho, Inc. · May 1993